INS and diabetes mellitus: This could explain the data shown in Tables 1, 2 and 3 that plasma amylin levels in diabetes were high when the average disease duration was shorter and the disease was milder so that insulin treatment was not needed; in contrast, the levels of plasma amylin were low regardless of insulin treatment when the diabetic duration was longer and the disease was severe.